Live news related to AB SCIENCE stock (FR0010557264): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Stonegate Capital Partners, an independent US-based research firm, updated its coverage of AB Science's stock on Tuesday following the release of the …
Maxim Group reaffirmed its buy recommendation for AB Science on Monday, with a target price of €4.00 per share. The analysis report, published on May …
AB Science announced its annual results for 2025, showing a non-recurring operating deficit reduced to €3.8 million, a 38% decrease from 2024. Includi…
AB Science announces the successful completion of a capital increase of 3.2 million euros with a select group of investors. The funds raised will prim…
AB Science announces the successful completion of a private placement totaling 3.2 million euros with a select group of investors. This capital increa…
AB Science announced on Monday a definitive agreement with all its financial creditors regarding the postponement of its debt repayment deadlines. Thi…
AB Science announced the publication of a new study on medRxiv assessing the benefits of masitinib in patients with amyotrophic lateral sclerosis. The…
AB Science has received a firm offer for clinical trial financing insurance covering up to €25 million in costs in the event of a failure of its phase…
AB Science stands out with a notable increase this Thursday morning, as its shares rise by 3.69% to 1.236 euros after closing at 1.19 euros the previo…
AB Science stock shows strong progress this Tuesday at midday, recording a gain of 4.15% at 1.306 euros. This advance occurs in a context of a signifi…
